Favipiravir Inhibits Zika Virus (ZIKV) Replication in HeLa Cells by Altering Viral Infectivity

This study aims to evaluate the antiviral potential of the nucleoside analogue favipiravir (FAV) against ZIKV, an arbovirus for which there are no approved antiviral therapies, in three human-derived cell lines. HeLa (cervical), SK-N-MC (neuronal), and HUH-7 (liver) cells were infected with ZIKV and...

Descripción completa

Detalles Bibliográficos
Autores principales: Franco, Evelyn J., Hanrahan, Kaley C., Brown, Ashley N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223361/
https://www.ncbi.nlm.nih.gov/pubmed/37317071
http://dx.doi.org/10.3390/microorganisms11051097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223361/
https://www.ncbi.nlm.nih.gov/pubmed/37317071
http://dx.doi.org/10.3390/microorganisms11051097

Ejemplares similares